Cargando…

Conferencia de Consenso sobre bronquiolitis aguda (II): epidemiología de la bronquiolitis aguda. Revisión de la evidencia científica()

A review of the evidence on epidemiology, risk factors, etiology and clinical-etiological profile of acute bronchiolitis is presented. The frequency estimates are very heterogeneous; in the population under two years the frequency of admission for bronchiolitis is between 1 and 3.5%, primary care co...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochoa Sangrador, C., González de Dios, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asociación Española de Pediatría. Published by Elsevier España S.L. 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105046/
https://www.ncbi.nlm.nih.gov/pubmed/20153707
http://dx.doi.org/10.1016/j.anpedi.2009.11.019
_version_ 1783512330576855040
author Ochoa Sangrador, C.
González de Dios, J.
author_facet Ochoa Sangrador, C.
González de Dios, J.
author_sort Ochoa Sangrador, C.
collection PubMed
description A review of the evidence on epidemiology, risk factors, etiology and clinical-etiological profile of acute bronchiolitis is presented. The frequency estimates are very heterogeneous; in the population under two years the frequency of admission for bronchiolitis is between 1 and 3.5%, primary care consultations between 4 and 20% and emergency visits between 1 and 2%. The frequency of admissions for respiratory infection by respiratory syncytial virus in the risk population is: in premature infants ≤32 weeks of gestation between 4.4 and 18%, in patients with bronchopulmonary dysplasia between 7.3 and 42%, and in infants with congenital heart disease between 1.6 and 9.8%. The main risk factors are: prematurity, chronic lung disease or bronchopulmonary dysplasia, congenital heart disease and age less than 3 – 6 months at onset of the epidemic. Other factors are: older siblings or day care attendance, male gender, exposure to smoking, breastfeeding for less than 1 – 2 months and variables associated with lower socioeconomic status. Respiratory syncytial virus is the dominant etiological agent, constituting just over half the cases (median 56%; interval 27% to 73%). Other viruses implicated, in descending order of frequency, are rhinovirus, adenovirus, metapneumovirus, influenza viruses, parainfluenza, enterovirus and bocavirus. In studies with genomic detection techniques, between 20 and 25% of cases the virus involved is not identified and between 9% and 27% of cases have viral co-infection. Although respiratory syncytial virus bronchiolitis shows more wheezing and retractions, longer duration of respiratory symptoms and oxygen therapy and are associated with lower use of antibiotics. This pattern is associated with the younger age of the patients and does not help us to predict the etiology. In general, the etiological identification is not useful for the management of patients. However, in young infants (<3 months) with febrile bronchiolitis in the hospital environment, conservative management may help these patients and avoid diagnostic and therapeutic procedures.
format Online
Article
Text
id pubmed-7105046
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Asociación Española de Pediatría. Published by Elsevier España S.L.
record_format MEDLINE/PubMed
spelling pubmed-71050462020-03-31 Conferencia de Consenso sobre bronquiolitis aguda (II): epidemiología de la bronquiolitis aguda. Revisión de la evidencia científica() Ochoa Sangrador, C. González de Dios, J. An Pediatr (Barc) Article A review of the evidence on epidemiology, risk factors, etiology and clinical-etiological profile of acute bronchiolitis is presented. The frequency estimates are very heterogeneous; in the population under two years the frequency of admission for bronchiolitis is between 1 and 3.5%, primary care consultations between 4 and 20% and emergency visits between 1 and 2%. The frequency of admissions for respiratory infection by respiratory syncytial virus in the risk population is: in premature infants ≤32 weeks of gestation between 4.4 and 18%, in patients with bronchopulmonary dysplasia between 7.3 and 42%, and in infants with congenital heart disease between 1.6 and 9.8%. The main risk factors are: prematurity, chronic lung disease or bronchopulmonary dysplasia, congenital heart disease and age less than 3 – 6 months at onset of the epidemic. Other factors are: older siblings or day care attendance, male gender, exposure to smoking, breastfeeding for less than 1 – 2 months and variables associated with lower socioeconomic status. Respiratory syncytial virus is the dominant etiological agent, constituting just over half the cases (median 56%; interval 27% to 73%). Other viruses implicated, in descending order of frequency, are rhinovirus, adenovirus, metapneumovirus, influenza viruses, parainfluenza, enterovirus and bocavirus. In studies with genomic detection techniques, between 20 and 25% of cases the virus involved is not identified and between 9% and 27% of cases have viral co-infection. Although respiratory syncytial virus bronchiolitis shows more wheezing and retractions, longer duration of respiratory symptoms and oxygen therapy and are associated with lower use of antibiotics. This pattern is associated with the younger age of the patients and does not help us to predict the etiology. In general, the etiological identification is not useful for the management of patients. However, in young infants (<3 months) with febrile bronchiolitis in the hospital environment, conservative management may help these patients and avoid diagnostic and therapeutic procedures. Asociación Española de Pediatría. Published by Elsevier España S.L. 2010-03 2010-02-13 /pmc/articles/PMC7105046/ /pubmed/20153707 http://dx.doi.org/10.1016/j.anpedi.2009.11.019 Text en Copyright © 2009 Asociación Española de Pediatría. Published by Elsevier España S.L. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ochoa Sangrador, C.
González de Dios, J.
Conferencia de Consenso sobre bronquiolitis aguda (II): epidemiología de la bronquiolitis aguda. Revisión de la evidencia científica()
title Conferencia de Consenso sobre bronquiolitis aguda (II): epidemiología de la bronquiolitis aguda. Revisión de la evidencia científica()
title_full Conferencia de Consenso sobre bronquiolitis aguda (II): epidemiología de la bronquiolitis aguda. Revisión de la evidencia científica()
title_fullStr Conferencia de Consenso sobre bronquiolitis aguda (II): epidemiología de la bronquiolitis aguda. Revisión de la evidencia científica()
title_full_unstemmed Conferencia de Consenso sobre bronquiolitis aguda (II): epidemiología de la bronquiolitis aguda. Revisión de la evidencia científica()
title_short Conferencia de Consenso sobre bronquiolitis aguda (II): epidemiología de la bronquiolitis aguda. Revisión de la evidencia científica()
title_sort conferencia de consenso sobre bronquiolitis aguda (ii): epidemiología de la bronquiolitis aguda. revisión de la evidencia científica()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105046/
https://www.ncbi.nlm.nih.gov/pubmed/20153707
http://dx.doi.org/10.1016/j.anpedi.2009.11.019
work_keys_str_mv AT ochoasangradorc conferenciadeconsensosobrebronquiolitisagudaiiepidemiologiadelabronquiolitisagudarevisiondelaevidenciacientifica
AT gonzalezdediosj conferenciadeconsensosobrebronquiolitisagudaiiepidemiologiadelabronquiolitisagudarevisiondelaevidenciacientifica
AT conferenciadeconsensosobrebronquiolitisagudaiiepidemiologiadelabronquiolitisagudarevisiondelaevidenciacientifica